CoChat

Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis

Open access
Yao, Lina, Fan, Peidong, Arolfo, Maria, Jiang, Zhan, Olive, M Foster, Zablocki, Jeff, Sun, Hai-Ling, Chu, Nancy, Lee, Jeongrim, Kim, Hee-Yong, Leung, Kwan, Shryock, John, Blackburn, Brent, Diamond, Ivan · 2010 · Nature Medicine
Cited by 97

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

There is no effective treatment for cocaine addiction despite extensive knowledge of the neurobiology of drug addiction. Here we show that a selective aldehyde dehydrogenase-2 (ALDH-2) inhibitor, ALDH2i, suppresses cocaine self-administration in rats and prevents cocaine- or cue-induced reinstatement in a rat model of cocaine relapse-like behavior. We also identify a molecular mechanism by which ALDH-2 inhibition reduces cocaine-seeking behavior: increases in tetrahydropapaveroline (THP) formation due to inhibition of ALDH-2 decrease cocaine-stimulated dopamine production and release in vitro and in vivo. Cocaine increases extracellular dopamine concentration, which activates dopamine D2 autoreceptors to stimulate cAMP-dependent protein kinase A (PKA) and protein kinase C (PKC) in primary ventral tegmental area (VTA) neurons. PKA and PKC phosphorylate and activate tyrosine hydroxylase, further increasing dopamine synthesis in a positive-feedback loop. Monoamine oxidase converts dopamine to 3,4-dihydroxyphenylacetaldehyde (DOPAL), a substrate for ALDH-2. Inhibition of ALDH-2 enables DOPAL to condense with dopamine to form THP in VTA neurons. THP selectively inhibits phosphorylated (activated) tyrosine hydroxylase to reduce dopamine production via negative-feedback signaling. Reducing cocaine- and craving-associated increases in dopamine release seems to account for the effectiveness of ALDH2i in suppressing cocaine-seeking behavior. Selective inhibition of ALDH-2 may have therapeutic potential for treating human cocaine addiction and preventing relapse.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nm.2200

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 31

  1. Volkow, N.D. & Li, T.K. Drug addiction: the neurobiology of behaviour gone awry. Nat. Rev. Neurosci. 5, 963–970 (2004). · DOI · Paper page
  2. Sofuoglu, M. & Kosten, T.R. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin. Emerg. Drugs 11, 91–98 (2006). · DOI · Paper page
  3. Gaval-Cruz, M. & Weinshenker, D. Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol. Interv. 9, 175–187 (2009). · DOI · Paper page
  4. Arolfo, M.P. et al. Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol. Clin. Exp. Res. 33, 1935–1944 (2009). · DOI
  5. Keung, W.M., Lazo, O., Kunze, L. & Vallee, B.L. Daidzin suppresses ethanol consumption by Syrian golden hamsters without blocking acetaldehyde metabolism. Proc. Natl. Acad. Sci. USA 92, 8990–8993 (1995). · doi:10.1073/pnas.92.19.8990
  6. Bossert, J.M., Ghitza, U.E., Lu, L., Epstein, D.H. & Shaham, Y. Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur. J. Pharmacol. 526, 36–50 (2005). · DOI · Paper page
  7. Hyman, S.E. & Malenka, R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2, 695–703 (2001). · DOI · Paper page
  8. Balter, M. New clues to brain dopamine control, cocaine addiction. Science 271, 909 (1996). · doi:10.1126/science.271.5251.909
  9. Berke, J.D. & Hyman, S.E. Addiction, dopamine and the molecular mechanisms of memory. Neuron 25, 515–532 (2000). · DOI · Paper page
  10. McCaffery, P. & Drager, U.C. High levels of a retinoic acid–generating dehydrogenase in the meso-telencephalic dopamine system. Proc. Natl. Acad. Sci. USA 91, 7772–7776 (1994). · DOI · Paper page
  11. Lamensdorf, I. et al. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Brain Res. 868, 191–201 (2000). · DOI
  12. Marchitti, S.A., Deitrich, R.A. & Vasiliou, V. Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacol Rev. 59, 125–150 (2007). · DOI · Paper page
  13. Kim, Y.M., Kim, M.N., Lee, J.J. & Lee, M.K. Inhibition of dopamine biosynthesis by tetrahydropapaveroline. Neurosci. Lett. 386, 1–4 (2005). · doi:10.1016/j.neulet.2005.04.105
  14. Brodie, M.S. & Dunwiddie, T.V. Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action. Naunyn Schmiedebergs Arch. Pharmacol. 342, 660–665 (1990). · DOI
  15. Chen, S.Y., Burger, R.I. & Reith, M.E. Extracellular dopamine in the rat ventral tegmental area and nucleus accumbens following ventral tegmental infusion of cocaine. Brain Res. 729, 294–296 (1996). · DOI
  16. Lacey, M.G., Mercuri, N.B. & North, R.A. Actions of cocaine on rat dopaminergic neurones in vitro. Br. J. Pharmacol. 99, 731–735 (1990). · DOI · Paper page
  17. Yao, L. et al. Dopamine and ethanol cause translocation of epsilonPKC associated with epsilonRACK: cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways. Mol. Pharmacol. 73, 1105–1112 (2008). · DOI
  18. Stuber, G.D. et al. Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons. Science 321, 1690–1692 (2008). · DOI · Paper page
  19. Myers, R.D. Anatomical 'circuitry' in the brain mediating alcohol drinking revealed by THP-reactive sites in the limbic system. Alcohol 7, 449–459 (1990). · doi:10.1016/0741-8329(90)90031-7
  20. Sombers, L.A., Beyene, M., Carelli, R.M. & Wightman, R.M. Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J. Neurosci. 29, 1735–1742 (2009). · DOI · Paper page
  21. Dickinson, S.D. et al. Dopamine D2 receptor–deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72, 148–156 (1999). · DOI · Paper page
  22. Hahn, J., Kullmann, P.H., Horn, J.P. & Levitan, E.S. D2 autoreceptors chronically enhance dopamine neuron pacemaker activity. J. Neurosci. 26, 5240–5247 (2006). · DOI
  23. Negus, S.S., Mello, N.K., Lamas, X. & Mendelson, J.H. Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 278, 879–890 (1996). · DOI
  24. Rassnick, S., Pulvirenti, L. & Koob, G.F. Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology (Berl.) 109, 92–98 (1992). · DOI · Paper page
  25. Saeedi, H., Remington, G. & Christensen, B.K. Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood. Schizophr. Res. 85, 222–231 (2006). · DOI
  26. Tinsley, R.B. et al. Dopamine D2 receptor knockout mice develop features of Parkinson disease. Ann. Neurol. 66, 472–484 (2009). · DOI
  27. Inoue, Y. et al. Nicotine and ethanol activate protein kinase A synergistically via Gi βγ subunits in nucleus accumbens/ventral tegmental cocultures: the role of dopamine D1/D2 and adenosine A2A receptors. J. Pharmacol. Exp. Ther. 322, 23–29 (2007). · DOI
  28. Yamauchi, T. & Fujisawa, H. A simple and sensitive fluorometric assay for tyrosine hydroxylase. Anal. Biochem. 89, 143–150 (1978). · doi:10.1016/0003-2697(78)90735-2
  29. Sherald, A.F., Sparrow, J.C. & Wright, T.R. A spectrophotometric assay for Drosophila dopa decarboxylase. Anal. Biochem. 56, 300–305 (1973). · doi:10.1016/0003-2697(73)90194-2
  30. Nagatsu, T. & Udenfriend, S. Photometric assay of dopamine-β-hydroxylase activity in human blood. Clin. Chem. 18, 980–983 (1972). · DOI · Paper page
  31. McFarland, K., Davidge, S.B., Lapish, C.C. & Kalivas, P.W. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J. Neurosci. 24, 1551–1560 (2004). · DOI · Paper page

Cited by

Metadata

Authors
Yao, L., Fan, P., Arolfo, M., Jiang, Z., Olive, M. F., Zablocki, J., Sun, H.-L., Chu, N., Lee, J., Kim, H.-Y., Leung, K., Shryock, J., Blackburn, B., & Diamond, I.
Venue
Nature Medicine
Published
2010-08-22
Volume
16
Issue
9
Pages
1024-1028
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2007792880
Cited by
97
References
10
FWCI
3.16
Type
journal article
Language
en
Update notices
addendum (2011-02-04)
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.